Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

Related Articles by Review for PubMed (Select 23526481)

1.

Importance of pharmacogenetics in the treatment of children with attention deficit hyperactive disorder: a case report.

Tan-Kam T, Suthisisang C, Pavasuthipaisit C, Limsila P, Puangpetch A, Sukasem C.

Pharmgenomics Pers Med. 2013;6:3-7. doi: 10.2147/PGPM.S36782. Epub 2013 Jan 11.

2.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
3.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
4.

The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.

de Leon J, Susce MT, Murray-Carmichael E.

Mol Diagn Ther. 2006;10(3):135-51. Review.

PMID:
16771600
5.

The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review.

Fleeman N, Martin Saborido C, Payne K, Boland A, Dickson R, Dundar Y, Fernández Santander A, Howell S, Newman W, Oyee J, Walley T.

Health Technol Assess. 2011 Sep;15(33):1-102. doi: 10.3310/hta15330. Review.

7.

Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

Zhou SF.

Clin Pharmacokinet. 2009;48(11):689-723. doi: 10.2165/11318030-000000000-00000. Review.

PMID:
19817501
8.

[The role of zinc in the treatment of hyperactivity disorder in children].

Dodig-Curković K, Dovhanj J, Curković M, Dodig-Radić J, Degmecić D.

Acta Med Croatica. 2009 Oct;63(4):307-13. Review. Croatian.

PMID:
20034331
9.

[Individualized pharmacotherapy based on cytochrome P-450 (CYP) genotyping].

Johansen PW, Bergan S, Rootwelt H, Kvittingen EA, Rugstad HE.

Tidsskr Nor Laegeforen. 2002 Nov 30;122(29):2781-3. Review. Norwegian.

PMID:
12523145
10.

Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.

Kirchheiner J, Seeringer A.

Biochim Biophys Acta. 2007 Mar;1770(3):489-94. Epub 2006 Oct 4. Review.

PMID:
17113714
11.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
12.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

14.

Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.

Arranz MJ, de Leon J.

Mol Psychiatry. 2007 Aug;12(8):707-47. Epub 2007 Jun 5. Review.

PMID:
17549063
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk